middle.news

How Imricor’s Real-Time MRI Tech Is Poised to Disrupt $12B Cardiac Ablation Market

8:06am on Tuesday 26th of August, 2025 AEST Healthcare
Read Story

How Imricor’s Real-Time MRI Tech Is Poised to Disrupt $12B Cardiac Ablation Market

8:06am on Tuesday 26th of August, 2025 AEST
Key Points
  • US FDA Premarket Approval submissions advancing
  • CE Mark approvals secured for second-generation MRI-compatible devices
  • First-in-man ventricular ablation performed in VISABL-VT trial
  • Customer pipeline expanded from 7 to 26 sites
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Imricor Medical Systems (ASX:IMR)
OPEN ARTICLE